Proteomics of lung cell biology and pulmonary disease

References

• Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature409, 860–921 (2001).
   PubMed Web of Science ®Google Scholar
• Mueller M, Martens L, Apweiler R. Annotating the human proteome: beyond establishing a parts list. Biochim. Biophys. Acta1774, 175–191 (2007).
   PubMed Web of Science ®Google Scholar
• Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science291, 1304–1351 (2001).
   PubMed Web of Science ®Google Scholar
• Hubbard TJ, Aken BL, Beal K et al. Ensembl (2007). Nucleic Acids Res.35, D610–D617 (2007).
   PubMed Web of Science ®Google Scholar
• Humphery-Smith I. A human proteome project with a beginning and an end. Proteomics4, 2519–2521 (2004).
   PubMed Web of Science ®Google Scholar
• Duncan MW, Hunsucker SW. Proteomics as a tool for clinically relevant biomarker discovery and validation. Exp. Biol. Med. (Maywood)230, 808–817 (2005).
   PubMed Web of Science ®Google Scholar
• Guo Y, Fu Z, Van Eyk JE. A proteomic primer for the clinician. Proc. Am. Thorac. Soc.4, 9–17 (2007).
   Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol.24, 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol.19, 242–247 (2001).
   PubMed Web of Science ®Google Scholar
• Anon. Proteomics’ new order. Nature437, 169–170 (2005).
   Google Scholar
• Freire SL, Wheeler AR. Proteome-on-a-chip: mirage, or on the horizon? Lab. Chip6, 1415–1423 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol.563, 23–60 (2005).
   PubMed Web of Science ®Google Scholar
• States DJ, Omenn GS, Blackwell TW et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol.24, 333–338 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics1, 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Rennard SI, Robbins RA. Biology of airway epithelial cells. In: The Lung: Scientific Foundations. Crystal RG, West JB, Weibel ER, Barnes PJ (Eds). Lippincott-Raven, PA, USA 448 (1997).
   Google Scholar
• Bowler RP, Ellison MC, Reisdorph N. Proteomics in pulmonary medicine. Chest130, 567–574 (2006).
   PubMed Web of Science ®Google Scholar
• Magi B, Bargagli E, Bini L, Rottoli P. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics6, 6354–6369 (2006).
   PubMed Web of Science ®Google Scholar
• Hirsch J, Hansen KC, Burlingame AL, Matthay MA. Proteomics: current techniques and potential applications to lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol.287, L1–L23 (2004).
   Web of Science ®Google Scholar
• Wattiez R, Falmagne P. Proteomics of bronchoalveolar lavage fluid. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.815, 169–178 (2005).
   PubMedGoogle Scholar
• Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics. Am. J. Respir. Cell. Mol. Biol.32, 169–176 (2005).
   PubMed Web of Science ®Google Scholar
• Ollero M, Brouillard F, Edelman A. Cystic fibrosis enters the proteomics scene: new answers to old questions. Proteomics6, 4084–4099 (2006).
   PubMed Web of Science ®Google Scholar
• Penque D. Proteomic biomarker discovery for the monogenic disease cystic fibrosis. Expert Rev. Proteomics4, 199–209 (2007).
   PubMed Web of Science ®Google Scholar
• Guo Y, Singleton PA, Rowshan A et al. Quantitative proteomic analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol. Cell. Proteomics6, 689–696 (2007).
   PubMed Web of Science ®Google Scholar
• Kanamoto T, Hellman U, Heldin CH, Souchelnytskyi S. Functional proteomics of transforming growth factor-β1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFβ1-dependent regulation of DNA repair. EMBO J.21, 1219–1230 (2002).
   PubMed Web of Science ®Google Scholar
• Jin M, Opalek JM, Marsh CB, Wu HM. Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics. Am. J. Respir. Cell. Mol. Biol.31, 322–329 (2004).
   PubMed Web of Science ®Google Scholar
• Wu HM, Jin M, Marsh CB. Toward functional proteomics of alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol.288, L585–L595 (2005).
   Web of Science ®Google Scholar
• Candiano G, Bruschi M, Pedemonte N et al. Proteomic analysis of the airway surface liquid: modulation by proinflammatory cytokines. Am. J. Physiol. Lung Cell. Mol. Physiol.292, L185–L198 (2007).
   Google Scholar
• Malmstrom J, Larsen K, Malmstrom L et al. Proteome annotations and identifications of the human pulmonary fibroblast. J. Proteome Res.3, 525–537 (2004).
   PubMed Web of Science ®Google Scholar
• Nicholas B, Skipp P, Mould R et al. Shotgun proteomic analysis of human-induced sputum. Proteomics6, 4390–4401 (2006).
   PubMed Web of Science ®Google Scholar
• Gianazza E, Allegra L, Bucchioni E et al. Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. Am. J. Med.117, 51–54 (2004).
   PubMed Web of Science ®Google Scholar
• Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics6, 6326–6353 (2006).
   PubMed Web of Science ®Google Scholar
• Bell DY, Hook GE. Pulmonary alveolar proteinosis: analysis of airway and alveolar proteins. Am. Rev. Respir. Dis.119, 979–990 (1979).
   PubMed Web of Science ®Google Scholar
• Noel-Georis I, Bernard A, Falmagne P, Wattiez R. Database of bronchoalveolar lavage fluid proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.771, 221–236 (2002).
   PubMed Web of Science ®Google Scholar
• Guo Y, Ma SF, Grigoryev D, Van Eyk J, Garcia JG. 1-DE MS and 2-D LC-MS analysis of the mouse bronchoalveolar lavage proteome. Proteomics5, 4608–4624 (2005).
   Google Scholar
• Wu J, Kobayashi M, Sousa EA et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol. Cell. Proteomics4, 1251–1264 (2005).
   PubMed Web of Science ®Google Scholar
• Greenlee KJ, Corry DB, Engler DA et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J. Immunol.177, 7312–7321 (2006).
   PubMed Web of Science ®Google Scholar
• Ghosh S, Janocha AJ, Aronica MA et al. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J. Immunol.176, 5587–5597 (2006).
   PubMed Web of Science ®Google Scholar
• Wattiez R, Noel-Georis I, Cruyt C, Broeckaert F, Bernard A, Falmagne P. Susceptibility to oxidative stress: proteomic analysis of bronchoalveolar lavage from ozone-sensitive and ozone-resistant strains of mice. Proteomics3, 658–665 (2003).
   PubMed Web of Science ®Google Scholar
• Jeong H, Rhim T, Ahn MH et al. Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J. Korean Med. Sci.20, 579–585 (2005).
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhu H, Wong CH, Leung KY, Wong WS. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics5, 2799–2807 (2005).
   PubMed Web of Science ®Google Scholar
• Welch JS, Escoubet-Lozach L, Sykes DB, Liddiard K, Greaves DR, Glass CK. Th2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J. Biol. Chem.277, 42821–42829 (2002).
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zheng T, Homer RJ et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science304, 1678–1682 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao J, Yeong LH, Wong WS. Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Int. Arch. Allergy Immunol.142, 219–229 (2007).
   Google Scholar
• Houtman R, Krijgsveld J, Kool M et al. Lung proteome alterations in a mouse model for nonallergic asthma. Proteomics3, 2008–2018 (2003).
   PubMed Web of Science ®Google Scholar
• Roh GS, Shin Y, Seo SW et al. Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics4, 3318–3327 (2004).
   PubMed Web of Science ®Google Scholar
• Nocker RE, van der Zee JS, Weller FR, van Overveld FJ, Jansen HM, Out TA. Segmental allergen challenge induces plasma protein leakage into the airways of asthmatic subjects at 4 hours but not at 5 minutes after challenge. J. Lab. Clin. Med.134, 74–82 (1999).
   Google Scholar
• Pinto-Plata V, Toso J, Lee K et al. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax62, 595–601 (2007).
   PubMed Web of Science ®Google Scholar
• Merkel D, Rist W, Seither P, Weith A, Lenter MC. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics5, 2972–2980 (2005).
   PubMed Web of Science ®Google Scholar
• Pollard HB, Eidelman O, Jozwik C et al. De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells. Mol. Cell. Proteomics5, 1628–1637 (2006).
   PubMed Web of Science ®Google Scholar
• Pollard HB, Ji XD, Jozwik C, Jacobowitz DM. High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics5, 2210–2226 (2005).
   PubMed Web of Science ®Google Scholar
• Roxo-Rosa M, da Costa G, Luider TM et al. Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease. Proteomics6, 2314–2325 (2006).
   PubMed Web of Science ®Google Scholar
• Brouillard F, Bensalem N, Hinzpeter A et al. Blue native/SDS-PAGE analysis reveals reduced expression of the mClCA3 protein in cystic fibrosis knock-out mice. Mol. Cell. Proteomics4, 1762–1775 (2005).
   PubMed Web of Science ®Google Scholar
• Schagger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal. Biochem.199, 223–231 (1991).
   PubMed Web of Science ®Google Scholar
• Bensalem N, Ventura AP, Vallee B et al. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol. Cell. Proteomics4, 1591–1601 (2005).
   PubMed Web of Science ®Google Scholar
• Sloane AJ, Lindner RA, Prasad SS et al. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am. J. Respir. Crit. Care Med.172, 1416–1426 (2005).
   PubMed Web of Science ®Google Scholar
• Schulz BL, Sloane AJ, Robinson LJ et al. Glycosylation of sputum mucins is altered in cystic fibrosis patients. Glycobiology17, 698–712 (2007).
   PubMed Web of Science ®Google Scholar
• Bai Y, Galetskiy D, Damoc E et al. High resolution mass spectrometric alveolar proteomics: identification of surfactant protein SP-A and SP-D modifications in proteinosis and cystic fibrosis patients. Proteomics4, 2300–2309 (2004).
   PubMed Web of Science ®Google Scholar
• Starosta V, Rietschel E, Paul K, Baumann U, Griese M. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest129, 431–437 (2006).
   PubMedGoogle Scholar
• Pedersen SK, Sloane AJ, Prasad SS et al. An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis. Mol. Cell. Proteomics4, 1052–1060 (2005).
   PubMed Web of Science ®Google Scholar
• Oh P, Li Y, Yu J et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature429, 629–635 (2004).
   PubMed Web of Science ®Google Scholar
• Chen G, Gharib TG, Wang H et al. Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl Acad. Sci. USA100, 13537–13542 (2003).
   PubMed Web of Science ®Google Scholar
• Shin BK, Wang H, Yim AM et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem.278, 7607–7616 (2003).
   PubMed Web of Science ®Google Scholar
• Huang LJ, Chen SX, Luo WJ, Jiang HH, Zhang PF, Yi H. Proteomic analysis of secreted proteins of non-small cell lung cancer. Ai Zheng25, 1361–1367 (2006).
   PubMedGoogle Scholar
• Campa MJ, Wang MZ, Howard B, Fitzgerald MC, Patz EF Jr. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res.63, 1652–1656 (2003).
   PubMedGoogle Scholar
• Rahman SM, Shyr Y, Yildiz PB et al. Proteomic patterns of preinvasive bronchial lesions. Am. J. Respir. Crit. Care Med.172, 1556–1562 (2005).
   PubMed Web of Science ®Google Scholar
• Cho NH, Koh ES, Lee DW et al. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J. Proteome Res.5, 643–650 (2006).
   Google Scholar
• Jin LJ, Shin BK, Jung WY et al. Proteomic analysis of pulmonary sclerosing hemangioma. Proteomics6, 4877–4883 (2006).
   Google Scholar
• Fujii K, Nakano T, Kanazawa M et al. Clinical-scale high-throughput human plasma proteome analysis: lung adenocarcinoma. Proteomics5, 1150–1159 (2005).
   PubMed Web of Science ®Google Scholar
• Okano T, Kondo T, Kakisaka T et al. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics6, 3938–3948 (2006).
   PubMed Web of Science ®Google Scholar
• Xiao T, Ying W, Li L et al. An approach to studying lung cancer-related proteins in human blood. Mol. Cell. Proteomics4, 1480–1486 (2005).
   PubMed Web of Science ®Google Scholar
• Yang SY, Xiao XY, Zhang WG et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer5, 83 (2005).
   PubMed Web of Science ®Google Scholar
• Gao WM, Kuick R, Orchekowski RP et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer5, 110 (2005).
   PubMedGoogle Scholar
• Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res.61, 7908–7912 (2001).
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Takeuchi T, Ueda K, Murao H, Shimizu A. Detection of eight antibodies in cancer patients’ sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.838, 15–20 (2006).
   PubMed Web of Science ®Google Scholar
• Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small-cell lung cancer. Am. J. Respir. Crit. Care Med.172, 1308–1314 (2005).
   PubMed Web of Science ®Google Scholar
• Tyan YC, Wu HY, Su WC, Chen PW, Liao PC. Proteomic analysis of human pleural effusion. Proteomics5, 1062–1074 (2005).
   PubMed Web of Science ®Google Scholar
• Tyan YC, Wu HY, Lai WW, Su WC, Liao PC. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry. J. Proteome Res.4, 1274–1286 (2005).
   Google Scholar
• Hsieh WY, Chen MW, Ho HT, You TM, Lu YT. Identification of differentially expressed proteins in human malignant pleural effusions. Eur. Respir. J.28, 1178–1185 (2006).
   PubMedGoogle Scholar
• Bard MP, Hegmans JP, Hemmes A et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell. Mol. Biol.31, 114–121 (2004).
   PubMed Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol.2, 569–579 (2002).
   PubMed Web of Science ®Google Scholar
• Hegmans JP, Bard MP, Hemmes A et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol.164, 1807–1815 (2004).
   PubMed Web of Science ®Google Scholar
• Tantipaiboonwong P, Sinchaikul S, Sriyam S, Phutrakul S, Chen ST. Different techniques for urinary protein analysis of normal and lung cancer patients. Proteomics5, 1140–1149 (2005).
   PubMed Web of Science ®Google Scholar
• Bowler RP, Duda B, Chan ED et al. Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol.286, L1095–L1104 (2004).
   PubMed Web of Science ®Google Scholar
• de Torre C, Ying SX, Munson PJ, Meduri GU, Suffredini AF. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics6, 3949–3957 (2006).
   PubMed Web of Science ®Google Scholar
• Schnapp LM, Donohoe S, Chen J et al. Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am. J. Pathol.169, 86–95 (2006).
   PubMed Web of Science ®Google Scholar
• Hirsch J, Hansen KC, Sapru A et al. Impact of low and high tidal volumes on the rat alveolar epithelial type II cell proteome. Am. J. Respir. Crit. Care Med.175, 1006–1013 (2007).
   Google Scholar
• Song Z, Marzilli L, Greenlee BM et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med.201, 755–767 (2005).
   PubMed Web of Science ®Google Scholar
• Kriegova E, Melle C, Kolek V et al. Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med.173, 1145–1154 (2006).
   PubMed Web of Science ®Google Scholar
• Bons JA, Drent M, Bouwman FG, Mariman EC, van Dieijen-Visser MP, Wodzig WK. Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum. Respir. Med.101, 1687–1695 (2007).
   PubMed Web of Science ®Google Scholar
• Wattiez R, Hermans C, Cruyt C, Bernard A, Falmagne P. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis21, 2703–2712 (2000).
   PubMed Web of Science ®Google Scholar
• Sabounchi-Schutt F, Astrom J, Hellman U, Eklund A, Grunewald J. Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach. Eur. Respir. J.21, 414–420 (2003).
   Web of Science ®Google Scholar
• Govender P, Baugh JA, Pennington SR, Dunn MJ, Donnelly SC. Role of proteomics in the investigation of pulmonary fibrosis. Expert Rev. Proteomics4, 379–388 (2007).
   PubMed Web of Science ®Google Scholar
• Rottoli P, Magi B, Perari MG et al. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics5, 1423–1430 (2005).
   PubMed Web of Science ®Google Scholar
• Magi B, Bini L, Perari MG et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis23, 3434–3444 (2002).
   PubMed Web of Science ®Google Scholar
• Fietta A, Bardoni A, Salvini R et al. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res. Ther.8, R160 (2006).
   PubMed Web of Science ®Google Scholar
• Larsen K, Malmstrom J, Wildt M et al. Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma. Respir. Res.7, 11 (2006).
   PubMed Web of Science ®Google Scholar
• Chaurasia G, Iqbal Y, Hanig C, Herzel H, Wanker EE, Futschik ME. UniHI: an entry gate to the human protein interactome. Nucleic Acids Res.35, D590–D594 (2007).
   Google Scholar
• Ewing RM, Chu P, Elisma F et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol.3, 89 (2007).
   PubMed Web of Science ®Google Scholar
• Wang X, Venable J, LaPointe P et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell127, 803–815 (2006).
   PubMed Web of Science ®Google Scholar
• Bertone P, Snyder M. Advances in functional protein microarray technology. FEBS J.272, 5400–5411 (2005).
   PubMed Web of Science ®Google Scholar
• Zhu H, Bilgin M, Bangham R et al. Global analysis of protein activities using proteome chips. Science293, 2101–2105 (2001).
   PubMed Web of Science ®Google Scholar
• Shen J, Zhang J, Luo X et al. Predicting protein–protein interactions based only on sequences information. Proc. Natl Acad. Sci. USA104, 4337–4341 (2007).
   PubMed Web of Science ®Google Scholar
• Zhu H, Hu S, Jona G et al. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc. Natl Acad. Sci. USA103, 4011–4016 (2006).
   PubMed Web of Science ®Google Scholar
• Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science298, 1912–1934 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson SA, Hunter T. Phosphoproteomics finds its timing. Nat. Biotechnol.22, 1093–1094 (2004).
   Google Scholar
• Hjerrild M, Gammeltoft S. Phosphoproteomics toolbox: computational biology, protein chemistry and mass spectrometry. FEBS Lett.580, 4764–4770 (2006).
   Google Scholar
• Morandell S, Stasyk T, Grosstessner-Hain K et al. Phosphoproteomics strategies for the functional analysis of signal transduction. Proteomics6, 4047–4056 (2006).
   PubMed Web of Science ®Google Scholar
• Reinders J, Sickmann A. State-of-the-art in phosphoproteomics. Proteomics5, 4052–4061 (2005).
   PubMed Web of Science ®Google Scholar
• Stern DF. Phosphoproteomics for oncology discovery and treatment. Expert Opin. Ther. Targets9, 851–860 (2005).
   PubMed Web of Science ®Google Scholar
• Bosques CJ, Raguram S, Sasisekharan R. The sweet side of biomarker discovery. Nat. Biotechnol.24, 1100–1101 (2006).
   PubMed Web of Science ®Google Scholar
• Dube DH, Bertozzi CR. Glycans in cancer and inflammation – potential for therapeutics and diagnostics. Nat. Rev. Drug Discov.4, 477–488 (2005).
   PubMed Web of Science ®Google Scholar
• Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science306, 640–643 (2004).
   PubMed Web of Science ®Google Scholar
• Hood L, Perlmutter RM. The impact of systems approaches on biological problems in drug discovery. Nat. Biotechnol.22, 1215–1217 (2004).
   PubMed Web of Science ®Google Scholar
• Kell DB. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov. Today11, 1085–1092 (2006).
   PubMed Web of Science ®Google Scholar
• Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics6, 4716–4723 (2006).
   PubMed Web of Science ®Google Scholar
• Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E. Cancer biomarkers: a systems approach. Nat. Biotechnol.24, 905–908 (2006).
   PubMed Web of Science ®Google Scholar
• Gauthier GL, Grimm R. Miniaturization: chip-based liquid chromatography and proteomics. Drug Discov. Today Technologies3, 59–66 (2006).
   Google Scholar
• DeVoe DL, Lee CS. Microfluidic technologies for MALDI-MS in proteomics. Electrophoresis27, 3559–3568 (2006).
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu H, Zhong W et al. Multilayer-assembled microchip for enzyme immobilization as reactor toward low-level protein identification. Anal. Chem.78, 801–808 (2006).
   PubMedGoogle Scholar
• Vasilescu J, Zweitzig DR, Denis NJ et al. The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells. J. Proteome Res.6, 298–305 (2007).
   Google Scholar
• Hou W, Ethier M, Smith JC, Sheng Y, Figeys D. Multiplexed proteomic reactor for the processing of proteomic samples. Anal. Chem.79, 39–44 (2007).
   Google Scholar